This is the last week to enter our hardwood floor giveaway in support of the Leukemia and Lymphoma Society. Don't miss your opportunity to enter and win! https://lnkd.in/e2HHF-NG
TH Custom Hardwood, LLC的动态
最相关的动态
-
The #BloodCancer landscape continues to evolve through scientific innovations that not only clinically benefit patients, but also strengthen their care and quality of life. ? ? Explore the emerging themes this year to watch for with The Leukemia & Lymphoma Society: https://e.lilly/3P0Rm3F??
要查看或添加评论,请登录
-
On World Lymphoma Awareness Day, we highlight the importance of early detection and support for those battling lymphoma. Together, we can make a difference by increasing awareness and advocating for research. #LymphomaAwareness #ltsi #WorldLymphomaDay
要查看或添加评论,请登录
-
In the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumors, CD5-negative B-cell prolymphocytic leukemia has been replaced. The new entity is known as splenic B-cell lymphoma/leukemia with prominent nucleoli. What are your thoughts on this update?
要查看或添加评论,请登录
-
This unique case underscores the challenges in diagnosing and managing ocular manifestations of mantle cell lymphoma, a rare and usually high-grade type of non-Hodgkin lymphoma. https://lnkd.in/eG_JKjeg #Ophthalmology #ClinicalResearch #OcularOncology
要查看或添加评论,请登录
-
Early detection, access to effective treatment, and ongoing funding for life-saving research are crucial in the fight against blood cancers like leukemia and lymphoma. #LeukemiaAwareness #LymphomaAwareness #BloodCancerAwareness #CancerAwareness #CancerResearch #CancerSurvivor #CancerFighter #MedicalAwareness
要查看或添加评论,请登录
-
Analyze in a different light! Join us in this webinar series on leukemia and lymphoma analysis
?? COMING TUESDAY: Join us for an exciting webinar series on leukemia and lymphoma analysis! Discover the benefits of a standardized workflow and witness a demonstration of the new DxFLEX flow cytometer. Don't miss out on this opportunity to enhance your diagnostic skills. We'll have sessions on: ? B-Cell Neoplasms ? T-Cell Neoplasms ? Myeloid Neoplasms Learn more and sign up now: https://becls.co/3TrSBez
要查看或添加评论,请登录
-
September is Leukemia & Lymphoma Awareness Month. ?? For those facing these challenges, ongoing follow-up and treatment management is crucial. Knowing the specific type of leukemia or lymphoma helps tailor the best care and predict outcomes. We're here to support you every step of the way! ??702.380.8300 ??Link in bio #ProCareHospice #LeukemiaAwareness #LymphomaAwareness #LasVegasHospice #LasVegasCare
要查看或添加评论,请登录
-
?? Did you know? Diffuse large b-cell lymphoma, the most common type of non-Hodgkin’s lymphoma in the US, affects 30,000 new patients each year. With a relapse rate of up to 40% within two years, ongoing advancements in treatment are critical. ? Good news is on the horizon: #DLBCL is curable in 60-70% of cases with initial therapy. ?? In ACCC’s partnership with The Leukemia and Lymphoma Society we have produced https://bit.ly/3WPkJe5, a guide designed to hone communication, clarify treatment expectations, and help boost patient confidence through shared decision-making. ?? https://bit.ly/3wMWJgT Access the guide, a communication road map, and resource library to transform DLBCL treatment and patient engagement. Will you be at #ASCO24? Come visit ACCC’s booth, we’ll see you in Chicago! #LymphomaAwareness #HealthCommunication
要查看或添加评论,请登录
-
Metabolic Regulation of Lymphoma Development: #AACRFellows Tak W. Mak will address this topic in a keynote lecture at the Fourth AACR International Meeting on Advances in Malignant Lymphoma (June 19-22, Philadelphia). Learn more: https://bit.ly/3IOXuIW #AACRlymph24
要查看或添加评论,请登录
-
Establishing rapport, building trust, and empowering patients with cancer are important outcomes of effective patient-provider communication. Learn more about key insights derived from ACCC and The Leukemia & Lymphoma Society focus groups in the most recent Oncology Issues: https://bit.ly/4ddUy5Q.
要查看或添加评论,请登录